The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The combination of ibrutinib and venetoclax (ABT-199) to achieve complete remissions in patients with relapsed/refractory mantle cell lymphoma: Preliminary results of the phase II AIM study.
 
Constantine Si Lun Tam
Honoraria - Abbvie; Janssen-Cilag
Research Funding - Abbvie; Janssen-Cilag
 
Andrew Warwick Roberts
No Relationships to Disclose
 
Mary Ann Anderson
No Relationships to Disclose
 
Sarah-Jane Dawson
No Relationships to Disclose
 
Rodney J Hicks
No Relationships to Disclose
 
Christiane Pott
No Relationships to Disclose
 
David A. Westerman
No Relationships to Disclose
 
Glenda Burke
No Relationships to Disclose
 
Sarah Kamel
No Relationships to Disclose
 
Martin H. Dreyling
Honoraria - Janssen-Cilag
Research Funding - Janssen-Cilag
 
Mark A Dawson
No Relationships to Disclose
 
John Francis Seymour
Honoraria - Abbvie; Janssen-Cilag